Your browser doesn't support javascript.
loading
IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis.
Szabo, Gyongyi; Mitchell, Mack; McClain, Craig J; Dasarathy, Srinivasan; Barton, Bruce; McCullough, Arthur J; Nagy, Laura E; Kroll-Desrosiers, Aimee; Tornai, David; Min, Hyesung Alice; Radaeva, Svetlana; Holbein, M E Blair; Casey, Lisa; Cuthbert, Jennifer.
  • Szabo G; Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Mitchell M; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • McClain CJ; Department of Medicine, University of Louisville, Louisville, Kentucky, USA.
  • Dasarathy S; Center for Microbiome and Human Health, Lerner Research Institute of the Cleveland Clinic, Cleveland, Ohio, USA.
  • Barton B; Department of Inflammation and Immunity, Lerner Research Institute of the Cleveland Clinic, Cleveland, Ohio, USA.
  • McCullough AJ; Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Nagy LE; Center for Microbiome and Human Health, Lerner Research Institute of the Cleveland Clinic, Cleveland, Ohio, USA.
  • Kroll-Desrosiers A; Department of Inflammation and Immunity, Lerner Research Institute of the Cleveland Clinic, Cleveland, Ohio, USA.
  • Tornai D; Department of Inflammation and Immunity, Lerner Research Institute of the Cleveland Clinic, Cleveland, Ohio, USA.
  • Min HA; Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Radaeva S; VA Central Western Massachusetts, Leeds, Massachusetts, USA.
  • Holbein MEB; Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Casey L; Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Cuthbert J; National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA.
Hepatology ; 76(4): 1058-1068, 2022 10.
Article en En | MEDLINE | ID: mdl-35340032
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pentoxifilina / Enfermedad Hepática en Estado Terminal / Hepatitis Alcohólica Tipo de estudio: Clinical_trials / Diagnostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pentoxifilina / Enfermedad Hepática en Estado Terminal / Hepatitis Alcohólica Tipo de estudio: Clinical_trials / Diagnostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2022 Tipo del documento: Article